The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia
- PMID: 15000758
- DOI: 10.1089/089771504322778631
The therapeutic efficacy conferred by the 5-HT(1A) receptor agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after experimental traumatic brain injury is not mediated by concomitant hypothermia
Abstract
We recently reported that the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) attenuated traumatic brain injury (TBI)-induced cognitive deficits and histopathology. However, 8-OH-DPAT also produced mild hypothermia (Hypo), which may have contributed to the benefit. To clarify this issue, we conducted an experiment similar to the previous, but included an 8-OH-DPAT group that was maintained at 37 +/- 0.5 degrees C (normothermia; Normo). Isoflurane-anesthetized rats received either a cortical impact (2.7-mm deformation at 4 m/sec) or sham injury and then were randomly assigned to two saline (Sham/Vehicle, n = 5; Injury/Vehicle, n = 10) or three 8-OH-DPAT (Sham/DPAT, n = 5; Injury/DPAT + Normo, n = 10; Injury/DPAT + Hypo, n = 10) groups. 8-OH-DPAT (0.5 mg/kg) or a comparable volume of saline was administered intraperitoneally 15 min after cortical impact or sham injury. Core temperatures were taken prior to treatment and every 15 min thereafter for 2 h. Function was assessed by established motor and cognitive tasks on post-operative days 1-5 and 14-20, respectively. Hippocampal CA1/CA3 cell survival and cortical lesion volume were quantified at 4 weeks. Both the Injury/DPAT + Normo and Injury/DPAT + Hypo groups exhibited enhanced cognitive performance (spatial acquisition and retention) and reduced histopathology (CA3 cell loss and cortical lesion volume) versus the Injury/ Vehicle group (P < 0.05), but did not differ from one another despite a rapid (15 min), mild (34.4-34.9 degrees C), and transient (~1 h) hypothermic effect in the latter. These data confirm that a single systemic administration of 8-OH-DPAT confers neurological protection after TBI, and demonstrate that the beneficial effect is not mediated by concomitant hypothermia. The mechanisms for the protective effects of 8-OH-DPAT after TBI require further inquiry.
Similar articles
-
Acute treatment with the 5-HT(1A) receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain trauma.Behav Brain Res. 2007 Feb 27;177(2):186-94. doi: 10.1016/j.bbr.2006.11.036. Epub 2006 Dec 12. Behav Brain Res. 2007. PMID: 17166603 Free PMC article.
-
Evaluation of a combined therapeutic regimen of 8-OH-DPAT and environmental enrichment after experimental traumatic brain injury.J Neurotrauma. 2010 Nov;27(11):2021-32. doi: 10.1089/neu.2010.1535. Epub 2010 Oct 28. J Neurotrauma. 2010. PMID: 21028935 Free PMC article.
-
Protective effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin against traumatic brain injury-induced cognitive deficits and neuropathology in adult male rats.Neurosci Lett. 2002 Nov 29;333(3):179-82. doi: 10.1016/s0304-3940(02)01101-1. Neurosci Lett. 2002. PMID: 12429377
-
Selective breeding of 5-HT(1A) receptor-mediated responses: application to emotion and receptor action.Pharmacol Biochem Behav. 2000 Dec;67(4):701-8. doi: 10.1016/s0091-3057(00)00415-9. Pharmacol Biochem Behav. 2000. PMID: 11166060 Review.
-
5-hydroxytryptamine1A (5-HT1A) receptor agonists: A decade of empirical evidence supports their use as an efficacious therapeutic strategy for brain trauma.Brain Res. 2016 Jun 1;1640(Pt A):5-14. doi: 10.1016/j.brainres.2015.11.026. Epub 2015 Nov 21. Brain Res. 2016. PMID: 26612522 Free PMC article. Review.
Cited by
-
Evaluation of a combined treatment paradigm consisting of environmental enrichment and the 5-HT1A receptor agonist buspirone after experimental traumatic brain injury.J Neurotrauma. 2012 Jul 1;29(10):1960-9. doi: 10.1089/neu.2012.2385. Epub 2012 May 21. J Neurotrauma. 2012. PMID: 22471653 Free PMC article.
-
Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits.Life Sci. 2008 Oct 24;83(17-18):602-7. doi: 10.1016/j.lfs.2008.08.007. Epub 2008 Aug 31. Life Sci. 2008. PMID: 18801378 Free PMC article.
-
Found in translation: Understanding the biology and behavior of experimental traumatic brain injury.Neurosci Biobehav Rev. 2015 Nov;58:123-46. doi: 10.1016/j.neubiorev.2014.12.004. Epub 2014 Dec 10. Neurosci Biobehav Rev. 2015. PMID: 25496906 Free PMC article. Review.
-
Environmental enrichment as a viable neurorehabilitation strategy for experimental traumatic brain injury.J Neurotrauma. 2014 May 15;31(10):873-88. doi: 10.1089/neu.2014.3328. Epub 2014 Apr 17. J Neurotrauma. 2014. PMID: 24555571 Free PMC article.
-
Acute treatment with the 5-HT(1A) receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain trauma.Behav Brain Res. 2007 Feb 27;177(2):186-94. doi: 10.1016/j.bbr.2006.11.036. Epub 2006 Dec 12. Behav Brain Res. 2007. PMID: 17166603 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous